Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 3
2011 3
2012 1
2013 1
2014 2
2015 2
2016 4
2017 4
2018 2
2019 8
2020 2
2021 3
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for gulseth n
Search for Guldseth N instead (1 results)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial.
Pieber TR, Bode B, Mertens A, Cho YM, Christiansen E, Hertz CL, Wallenstein SOR, Buse JB; PIONEER 7 investigators. Pieber TR, et al. Lancet Diabetes Endocrinol. 2019 Jul;7(7):528-539. doi: 10.1016/S2213-8587(19)30194-9. Epub 2019 Jun 9. Lancet Diabetes Endocrinol. 2019. PMID: 31189520 Clinical Trial.
FINDINGS: Between Sept 20, 2016, and Feb 7, 2017, of 804 patients assessed for eligibility, 504 were eligible and randomly assigned to oral semaglutide (n=253) or sitagliptin (n=251). Most participants were male (285 [57%] of 504) with a mean age of 57.4 years (SD 9 …
FINDINGS: Between Sept 20, 2016, and Feb 7, 2017, of 804 patients assessed for eligibility, 504 were eligible and randomly assigned to oral …
Coronavirus immunisation abroad among foreign-born persons in Norway.
Nilsen TS, Gulseth HL, Daae A, Indseth T. Nilsen TS, et al. Tidsskr Nor Laegeforen. 2022 Jun 27;142(10). doi: 10.4045/tidsskr.22.0052. Print 2022 Jun 28. Tidsskr Nor Laegeforen. 2022. PMID: 35763856 Free article. English, Norwegian.
The survey was conducted online and the response rate was 41 % (n = 108 738). RESULTS: A total of 105 010 (97 %) of the respondents had had at least one dose of the coronavirus vaccine. ...
The survey was conducted online and the response rate was 41 % (n = 108 738). RESULTS: A total of 105 010 (97 %) of the respondents h …
Undiagnosed diabetes based on HbA1c by socioeconomic status and healthcare consumption in the Tromsø Study 1994-2016.
Ruiz PL, Hopstock LA, Eggen AE, Njølstad I, Grimnes G, Stene LC, Gulseth HL. Ruiz PL, et al. BMJ Open Diabetes Res Care. 2021 Nov;9(2):e002423. doi: 10.1136/bmjdrc-2021-002423. BMJ Open Diabetes Res Care. 2021. PMID: 34782335 Free PMC article.
RESEARCH DESIGN AND METHODS: In this cohort study, we studied age-standardized diabetes prevalence using data from men and women aged 40-89 years participating in four surveys of the Tromso Study with available data on HbA(1c) and self-reported diabetes: 1994-1995 (n=6720) …
RESEARCH DESIGN AND METHODS: In this cohort study, we studied age-standardized diabetes prevalence using data from men and women aged 40-89 …
Cardiovascular disease risk profiles in inflammatory joint disease entities.
Wibetoe G, Ikdahl E, Rollefstad S, Olsen IC, Bergsmark K, Kvien TK, Salberg A, Soldal DM, Bakland G, Lexberg Å, Fevang BT, Gulseth HC, Haugeberg G, Semb AG. Wibetoe G, et al. Arthritis Res Ther. 2017 Jul 3;19(1):153. doi: 10.1186/s13075-017-1358-1. Arthritis Res Ther. 2017. PMID: 28673314 Free PMC article.
Antidiabetic medication use during pregnancy: an international utilization study.
Cesta CE, Cohen JM, Pazzagli L, Bateman BT, Bröms G, Einarsdóttir K, Furu K, Havard A, Heino A, Hernandez-Diaz S, Huybrechts KF, Karlstad Ø, Kieler H, Li J, Leinonen MK, Gulseth HL, Tran D, Yu Y, Zoega H, Odsbu I. Cesta CE, et al. BMJ Open Diabetes Res Care. 2019 Nov 2;7(1):e000759. doi: 10.1136/bmjdrc-2019-000759. eCollection 2019. BMJ Open Diabetes Res Care. 2019. PMID: 31798900 Free PMC article.
RESULTS: Prevalence of any ADM use in 5 279 231 pregnancies was 3% (n=147 999) and varied from under 2% (Denmark, Norway, and Sweden) to above 5% (Australia and US). ...
RESULTS: Prevalence of any ADM use in 5 279 231 pregnancies was 3% (n=147 999) and varied from under 2% (Denmark, Norway, and Sweden) …
Insulin and Body Mass Index Decrease Serum Soluble Leptin Receptor Levels in Humans.
Sommer C, Vangberg KG, Moen GH, Evans DM, Lee-Ødegård S, Blom-Høgestøl IK, Sletner L, Jenum AK, Drevon CA, Gulseth HL, Birkeland KI. Sommer C, et al. J Clin Endocrinol Metab. 2023 Apr 13;108(5):1110-1119. doi: 10.1210/clinem/dgac699. J Clin Endocrinol Metab. 2023. PMID: 36459457 Free PMC article.
METHODS: We performed an epidemiological triangulation combining cross-sectional, interventional, and Mendelian randomization study designs. In 5 independent clinical studies (n = 24-823), sOb-R was quantified in serum or plasma by commercial enzyme-linked immunosorbent as …
METHODS: We performed an epidemiological triangulation combining cross-sectional, interventional, and Mendelian randomization study designs. …
Effects of liraglutide vs. lifestyle changes on soluble suppression of tumorigenesis-2 (sST2) and galectin-3 in obese subjects with prediabetes or type 2 diabetes after comparable weight loss.
Simeone P, Tripaldi R, Michelsen A, Ueland T, Liani R, Ciotti S, Birkeland KI, Gulseth HL, Di Castelnuovo A, Cipollone F, Aukrust P, Consoli A, Halvorsen B, Santilli F. Simeone P, et al. Cardiovasc Diabetol. 2022 Mar 11;21(1):36. doi: 10.1186/s12933-022-01469-w. Cardiovasc Diabetol. 2022. PMID: 35277168 Free PMC article. Clinical Trial.
METHODS: Forty metformin-treated obese subjects (BMI 30) with prediabetes [impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) or both (n = 23)] or newly diagnosed T2DM (n = 17), were randomized to liraglutide or lifestyle counseling until achieving a …
METHODS: Forty metformin-treated obese subjects (BMI 30) with prediabetes [impaired fasting glucose (IFG) or impaired glucose tolerance (IGT …
34 results